Cardiovascular Disease Update Part 1 The European Society of Cardiology (ESC) has updated its guideline on management of high ...
Moreover, increase in approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets and rise in cases of chronic kidney disease is expected to propel growth of ...
The VALUE trial compared the effect of an ARB (valsartan) with a CCB (amlodipine), both in the whole cohort as well as in the diabetic subgroup. No significant difference in the composite cardiac ...